NCT04852289View on ClinicalTrials.gov

A Clinical Observational Study of SARS-CoV-2 Specific CD8 T-Cell Responses to COVID-19 Vaccines in Humans

Active, not recruitingOBSERVATIONAL

Enrollment

78

Participants

Timeline

Start Date

April 20, 2021

Primary Completion Date

December 4, 2025

Study Completion Date

June 30, 2027

Conditions

COVID-19

Trial Locations (2)

21224

National Institute of Aging, Clinical Research Unit, Baltimore

21244

NIH/NIA/Biomedical Research Center at Johns Hopkins Bayview campus, Baltimore

All Listed Sponsors

lead

National Institute on Aging (NIA)

NIH